Role of glycogen synthase kinase-3β inhibitor AZD1080 in ovarian cancer

References

• PiekJMvan DiestPJVerheijenRHOvarian carcinogenesis: an alternative hypothesisAdv Exp Med Biol2008622798718546620
   PubMed Web of Science ®Google Scholar
• BanderaCAAdvances in the understanding of risk factors for ovarian cancerJ Reprod Med200550639940616050564
   PubMed Web of Science ®Google Scholar
• CohenPFrameSThe renaissance of GSK3Nat Rev Mol Cell Biol200121076977611584304
   PubMed Web of Science ®Google Scholar
• DobleBWWoodgettJRGSK-3: tricks of the trade for a multi-tasking kinaseJ Cell Sci2003116Pt 71175118612615961
   PubMed Web of Science ®Google Scholar
• KotliarovaSPastorinoSKovellLCGlycogen synthase kinase-3 inhibition induces glioma cell death through c-MYC, nuclear factor-kappaB, and glucose regulationCancer Res200868166643665118701488
   PubMed Web of Science ®Google Scholar
• SalimTSjölanderASand-DejmekJNuclear expression of glycogen synthase kinase-3beta and lack of membranous beta-catenin is correlated with poor survival in colon cancerInt J Cancer2013133480781523389968
   PubMed Web of Science ®Google Scholar
• MishraRGlycogen synthase kinase 3 beta: can it be a target for oral cancerMol Cancer20109114420537194
   PubMedGoogle Scholar
• TangQLXieXBWangJGlycogen synthase kinase-3β, NF-κB signaling, and tumorigenesis of human osteosarcomaJ Natl Cancer Inst20121041074976322534782
   PubMedGoogle Scholar
• MadhunapantulaSVSharmaAGowdaRRobertsonGPIdentification of glycogen synthase kinase 3alpha as a therapeutic target in melanomaPigment Cell Melanoma Res201326688689924034838
   PubMed Web of Science ®Google Scholar
• RaskKNilssonABrännströmMWnt-signalling pathway in ovarian epithelial tumours: increased expression of beta-catenin and GSK3betaBr J Cancer20038971298130414520463
   PubMed Web of Science ®Google Scholar
• MarchandBTremblayICagnolSBoucherMJInhibition of glycogen synthase kinase-3 activity triggers an apoptotic response in pancreatic cancer cells through JNK-dependent mechanismsCarcinogenesis201233352953722201186
   PubMed Web of Science ®Google Scholar
• ZhuQYangJHanSSuppression of glycogen synthase kinase 3 activity reduces tumor growth of prostate cancer in vivoProstate201171883584521456066
   PubMed Web of Science ®Google Scholar
• ShakooriAMaiWMiyashitaKInhibition of GSK-3 beta activity attenuates proliferation of human colon cancer cells in rodentsCancer Sci20079891388139317640304
   PubMed Web of Science ®Google Scholar
• HolmesTO’BrienTAKnightRGlycogen synthase kinase-3beta inhibition preserves hematopoietic stem cell activity and inhibits leukemic cell growthStem Cells20082651288129718323411
   PubMed Web of Science ®Google Scholar
• GeorgievskaBSandinJDohertyJAZD1080, a novel GSK3 inhibitor, rescues synaptic plasticity deficits in rodent brain and exhibits peripheral target engagement in humansJ Neurochem2013125344645623410232
   PubMed Web of Science ®Google Scholar
• LivakKJSchmittgenTDAnalysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) MethodMethods200125440240811846609
   PubMed Web of Science ®Google Scholar
• ChouCHChouAKLinCCGSK3β regulates Bcl2L12 and Bcl2L12A anti-apoptosis signaling in glioblastoma and is inhibited by LiClCell Cycle201211353254222262180
   PubMed Web of Science ®Google Scholar
• LiTLaiQWangSMicroRNA-224 sustains Wnt/β-catenin signaling and promotes aggressive phenotype of colorectal cancerJ Exp Clin Cancer Res20163512126822534
   PubMedGoogle Scholar
• MarchandBTremblayICagnolSBoucherMJInhibition of glycogen synthase kinase-3 activity triggers an apoptotic response in pancreatic cancer cells through JNK-dependent mechanismsCarcinogenesis201233352953722201186
   PubMed Web of Science ®Google Scholar
• ShakooriAOugolkovAYuZWDeregulated GSK3beta activity in colorectal cancer: its association with tumor cell survival and proliferationBiochem Biophys Res Commun200533441365137316043125
   PubMed Web of Science ®Google Scholar
• MazorMKawanoYZhuHWaxmanJKyptaRMInhibition of glycogen synthase kinase-3 represses androgen receptor activity and prostate cancer cell growthOncogene200423477882789215361837
   PubMed Web of Science ®Google Scholar
• CazalesMSchmittEMontembaultEDozierCPrigentCDucommunBCDC25B phosphorylation by Aurora-A occurs at the G2/M transition and is inhibited by DNA damageCell Cycle2005491233123816082213
   PubMed Web of Science ®Google Scholar
• LindqvistAKallstromHLundgrenABarsoumERosenthalCKCdc25B cooperates with Cdc25A to induce mitosis but has a unique role in activating cyclin B1-Cdk1 at the centrosomeJ Cell Biol20051711354516216921
   PubMed Web of Science ®Google Scholar
• ChangWLYuCCChenCSGuhJHTubulin-binding agents down-regulate matrix metalloproteinase-2 and -9 in human hormone-refractory prostate cancer cells – a critical role of Cdk1 in mitotic entryBiochem Pharmacol2015941122125615907
   PubMed Web of Science ®Google Scholar
• ShiXNLiHYaoHIn silico identification and in vitro and in vivo validation of anti-psychotic drug fluspirilene as a potential CDK2 inhibitor and a candidate anti-cancer drugPLoS One2015107e013207226147897
   PubMed Web of Science ®Google Scholar
• ChienAJMooreECLonsdorfASActivated Wnt/beta-catenin signaling in melanoma is associated with decreased proliferation in patient tumors and a murine melanoma modelProc Natl Acad Sci U S A200910641193119819144919
   PubMed Web of Science ®Google Scholar
• LinPLiuJRenMIdebenone protects against oxidized low density lipoprotein induced mitochondrial dysfunction in vascular endothelial cells via GSK3β/β-catenin signalling pathwaysBiochem Biophys Res Commun2015465354855526284974
   PubMed Web of Science ®Google Scholar
• CampaVMBaltziskuetaEBengoa-VergnioryNA screen for transcription factor targets of glycogen synthase kinase-3 highlights an inverse correlation of NFκB and androgen receptor signaling in prostate cancerOncotarget20145188173818725327559
   PubMedGoogle Scholar
• GaoXHeYGaoLMSer9-phosphorylated GSK3β induced by 14-3-3ζ actively antagonizes cell apoptosis in a NF-κB dependent mannerBiochem Cell Biol201492534935625138042
   PubMed Web of Science ®Google Scholar
• BaoHGeYPengAGongRFine-tuning of NFκB by glycogen synthase kinase 3β directs the fate of glomerular podocytes upon injuryKidney Int20158761176119025629551
   PubMed Web of Science ®Google Scholar